1. Home
  2. ARMP vs NCMI Comparison

ARMP vs NCMI Comparison

Compare ARMP & NCMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Armata Pharmaceuticals Inc.

ARMP

Armata Pharmaceuticals Inc.

SELL

Current Price

$3.02

Market Cap

199.7M

Sector

Health Care

ML Signal

SELL

Logo National CineMedia Inc.

NCMI

National CineMedia Inc.

SELL

Current Price

$1.39

Market Cap

207.0M

ML Signal

SELL

Company Overview

Basic Information
Metric
ARMP
NCMI
Founded
N/A
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Advertising
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
199.7M
207.0M
IPO Year
1996
2006

Fundamental Metrics

Financial Performance
Metric
ARMP
NCMI
Price
$3.02
$1.39
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
4
Target Price
★ $17.50
$3.75
AVG Volume (30 Days)
75.7K
★ 755.7K
Earning Date
11-12-2026
11-10-2026
Dividend Yield
N/A
★ 4.05%
EPS Growth
N/A
★ 52.17
EPS
N/A
★ N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$14.18
Revenue Next Year
N/A
$16.67
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.40
$1.40
52 Week High
$14.98
$4.34

Technical Indicators

Market Signals
Indicator
ARMP
NCMI
Relative Strength Index (RSI) 46.59 34.43
Support Level $2.77 N/A
Resistance Level $3.96 $2.30
Average True Range (ATR) 0.44 0.18
MACD -0.02 -0.00
Stochastic Oscillator 43.35 2.96

Price Performance

Historical Comparison
ARMP
NCMI

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.

About NCMI National CineMedia Inc.

National CineMedia Inc is a cinema advertising platform in the U.S. It derives revenue from the sale of advertising to national, regional and local businesses through The Noovie Show and the CineLife Show, the cinema advertising and entertainment show seen on movie screens across the U.S., on LEN, a series of strategically-placed screens located in movie theater lobbies, as well as other forms of advertising and promotions in theater lobbies.

Share on Social Networks: